Previous Close | 160.44 |
Open | 160.88 |
Bid | 162.31 x 800 |
Ask | 162.29 x 800 |
Day's Range | 160.76 - 162.72 |
52 Week Range | 123.04 - 162.72 |
Volume | |
Avg. Volume | 769,879 |
Market Cap | 18.147B |
Beta (5Y Monthly) | 0.89 |
PE Ratio (TTM) | 21.85 |
EPS (TTM) | 7.44 |
Earnings Date | Jan 30, 2025 - Feb 03, 2025 |
Forward Dividend & Yield | 3.00 (1.87%) |
Ex-Dividend Date | Jan 14, 2025 |
1y Target Est | 167.10 |
Stryker launches the next generation of SurgiCount+ to boost sponge management and blood loss assessment in hospitals.
Quest Diagnostics' (NYSE:DGX) stock is up by a considerable 5.0% over the past month. As most would know, fundamentals...